Skip to main content

Articles

Page 1 of 8

  1. Cancer treatment continues to face significant challenges, including lack of selectivity, systemic toxicity, and the adaptive resistance mechanisms of cancer cells, which limit the effectiveness of conventiona...

    Authors: Giovanna Cassone Salata, Camila Megumi Hirokawa, Giovanna Barros de Melo, Isabella Draszesski Malagó, Jessica Ribeiro Nunes, Julia Sapienza Passos, Regina Gomes Daré and Luciana B. Lopes
    Citation: Cancer Nanotechnology 2025 16:21
  2. Compared with curcumin, bisdemethoxycurcumin, a dimethoxy derivative of curcumin, is a bioactive compound with greater anti-inflammatory and anticancer effects. However, its hydrophobic nature, rapid metabolis...

    Authors: Adedoyin O. Adefisan-Adeoye, Adewale O. Oladipo, Gurgur Emmanuel, Opawoye I. Adesewa, Jeremiah O. Unuofin, Temitope D. Adeoye, Sogolo L. Lebelo and Oluwatosin A. Adaramoye
    Citation: Cancer Nanotechnology 2025 16:19
  3. Colorectal cancer (CRC) is one of the most fatal malignant neoplasms around the world. Artemisinin (ART) displays broad anticancer properties with some drawbacks. Therefore, we tried to enhance the anticancer ...

    Authors: Zeinab Dwidar, Walaa F. Awadin, Mohamed El-Adl, Mohamed Abomosallam, Aya Aly ELzeer and Ahmed M. Abdellatif
    Citation: Cancer Nanotechnology 2025 16:18
  4. In recent years, the rising occurrence of cancer, particularly breast cancer, has led to a growing interest in utilizing nanotechnology for treatment. As a result of the significant side effects of chemical dr...

    Authors: Shima Bourang, Sodabeh Jahanbakhsh Godehkahriz, Mehran Noruzpour, Rasool Asghari Zakaria and Sergio Granados-Principal
    Citation: Cancer Nanotechnology 2025 16:17
  5. Breast cancer remains to be one of the most prevalent cancers in women, requiring enhanced treatment approaches. This research improved the formulation of oxaliplatin-loaded PEGylated niosomes with a Central C...

    Authors: Nastaran Asghari Moghaddam, Azadeh Mohammadgholi, Fatemeh Mojtahedi, Niyayesh Akhtari, Nasim Kaveh Farsani and Hassan Noorbazargan
    Citation: Cancer Nanotechnology 2025 16:16
  6. Gastric cancer (GC) progression is influenced through the dysregulation of the cell death and chronic inflammation, which together foster a tumor-promoting microenvironment and enhance cancer cell survival. Ta...

    Authors: Abdus Samad, Abishek Gnanasekaran and Yeon Ju Kim
    Citation: Cancer Nanotechnology 2025 16:15
  7. Gastric cancer (GC) remains a leading cause of cancer-related mortality worldwide. The prognosis for advanced GC is poor, necessitating innovative therapeutic strategies. Small interfering RNA (siRNA) offers a...

    Authors: Peng Cheng, Zhengrong Zhong, Yanling Wang, Caituan Feng, Jitong Zheng, SuogaoWang, Xiangjun Meng and Dong Wang
    Citation: Cancer Nanotechnology 2025 16:14
  8. Glioblastoma (GBM), classified as a grade IV glioma, poses a significant challenge in the medical field due to the lack of efficient early detection techniques and targeted treatment options. This review addre...

    Authors: Kimia Kazemi, Abbas Amini, Navid Omidifar, Safieh Aghabdollahian, Mohmmad Javad Raee and Ahmad Gholami
    Citation: Cancer Nanotechnology 2025 16:13
  9. We assessed the therapeutic potential of a combination of dendrimer generation 2 (G2) + doxorubicin (DOX) + peptide IF7 on colorectal cells. The researchers utilized regular examinations to assess the dimensio...

    Authors: Omid Reza Tamtaji, Mehdi Shafiee Ardestani, Abdolkarim Talebi Taheri, Michael R. Hamblin, Tina Rahjoo, Fatemeh Nabavizadeh and Hamed Mirzaei
    Citation: Cancer Nanotechnology 2025 16:11
  10. Vincristine (VIN) inhibits microtubule formation in the mitotic spindle, effectively arresting cells in mitosis. This study aimed to develop a polyethylene glycol (PEG)-functionalized UiO-66 metal–organic fram...

    Authors: Zahra Sadeghi Jam, Farzaneh Tafvizi, Parvin Khodarahmi, Parvaneh Jafari and Fahimeh Baghbani-Arani
    Citation: Cancer Nanotechnology 2025 16:10
  11. One intriguing therapy option for cancer is the peptide Melittin. This study assessed the in vitro anticancer effects of Melittin, Melittin-loaded pectin, and free pectin on mammary cell lines.

    Authors: Esmaeil Alibeigi, Arsham Azari Dehkordi, Milad Asadian, Abbas Doosti and Tohid Piri-Gharaghie
    Citation: Cancer Nanotechnology 2025 16:9
  12. Lung cancer has a poor prognosis with traditional treatments. Realgar (AS4S4), a traditional Chinese medicine, exhibits chemotherapeutic efficacy. However, its low solubility, complex dosage form, and limited the...

    Authors: Tao Jiang, Zhifei Huang, Mingdong Reng, Yuwei Ma, Bo Gao, Shilong Song, Fei Liu, Xiangyu Zhang, Jingwen Huang, Zelai He, Huijun Zhang, Jing Ma and Gengming Wang
    Citation: Cancer Nanotechnology 2025 16:8
  13. Glycosylation alterations have emerged as significant indicators in the landscape of cancer diagnosis, with aberrant N-glycans standing out as potential biomarkers. The existing methods for purifying N-glycans...

    Authors: Xuyuan Chao, Shengjie Yang, Baoying Zhang, Xin Zang, Jingyi Zhang, Xizi Liu, Lu Chen, Lu Qi, Xiaofeng Xue, Han Hu and Xinghe Wang
    Citation: Cancer Nanotechnology 2025 16:7
  14. Since silver nanoparticles (Ag NPs) may not perform well due to low solubility and passive entry, two types of drug delivery systems based on halloysite nanotubes (HNTs) were synthesized. These systems aim to ...

    Authors: Mostafa Heidari Majd, Kimia Behrouz Moghadam and Hong Wang
    Citation: Cancer Nanotechnology 2025 16:6
  15. Gastric cancer (GC), characterized by its high incidence and mortality, poses a great threat to public health worldwide. Although various advanced treatments have been developed for GC, the cure rate remains p...

    Authors: Junjia Wu, Kun Du, Ying Bao, Mengyuan Xiong, Jun Chen, Ziyan Luo, Dinglin Zhang and Yan Shi
    Citation: Cancer Nanotechnology 2025 16:5
  16. Oral squamous cell carcinoma (OSCC) treatment represents a great challenge, since platinum-based therapeutic agents have deleterious effects on normal cells and tissues. Employing gold nanoparticles (AuNps) as...

    Authors: Basma Abdelrahman Ahmed, Rania Osama M. Mohsen, Marwa Sharaky, Marwa A. Ramadan, Amna H. Faid and Mai Hafez Mohamed
    Citation: Cancer Nanotechnology 2025 16:4
  17. In the realm of cancer treatment, sono–X-ray–photodynamic therapy (SXPDT) has garnered significant interest as a novel therapeutic approach. The essential part of SXPDT is the sensitizer, which under X-ray pho...

    Authors: Samir Ali Abd El-Kaream, Abed Elrahman Ahmad Mohamad, Sohier Mahmoud El-Kholey and Samia Abd El-Moniem Ebied
    Citation: Cancer Nanotechnology 2025 16:3
  18. Kaposi's sarcoma-associated herpesvirus (KSHV) infection can cause a variety of tumors and is one of the leading causes of death in acquired immune deficiency syndrome (AIDS) patients. As a small molecule anti...

    Authors: Fangling Li, Chengjing Liu, Wenyi Gu, Qianhe Xu, Dongmei Li, Dongdong Cao and Zhiyong Liu
    Citation: Cancer Nanotechnology 2025 16:1
  19. Colorectal cancer (CRC) represents a substantial global health burden, necessitating advancements in diagnostic and therapeutic modalities. This study aimed to investigate the potential of CeO2/GO nanoparticles (...

    Authors: Omid Reza Tamtaji, Amirreza Ostadian, Mina Homayoonfal, Majid Nejati, Maryam Mahjoubin-Tehran, Fatemeh Nabavizadeh, Elaheh Ghelichi, Bahareh Mohammadzadeh, Merat Karimi, Neda Rahimian and Hamed Mirzaei
    Citation: Cancer Nanotechnology 2024 15:62
  20. To overcome the drug resistance in MCF7 cancer cells and enhance their sensitivity to cisplatin, a liposomal (Lip) nanocarrier modified by arginine-glycine-aspartic acid (RGD) to co-deliver cisplatin (Cis) and...

    Authors: Hassan Bardania, Marzieh Baneshi, Reza Mahmoudi, Fatemeh Khosravani, Farshad Safari, Bahman Khalvati, Abdollah Poursamad and Mohsen Alipour
    Citation: Cancer Nanotechnology 2024 15:60
  21. Cervical cancer is a significant cause of death among women worldwide, and limited treatment approaches are available for patients with metastatic or recurrent disease. Recently, the combination of nanoparticl...

    Authors: Chanyatip Suwannasing, Nittiya Suwannasom, Peerawit Soonthornchookiat, Pitchayuth Srisai, Chatrawut Pattaweerakul, Suchart Kothan and Ausanai Prapan
    Citation: Cancer Nanotechnology 2024 15:59
  22. Antihyperglycemic drug artemisinin (Art) has recently gained attention as a potential anticancer treatment. In this study, the poly(lactic-co-glycolic acid) (PLGA) polymer was used to create Art-containing nan...

    Authors: Mohammad Eslami Vaghar, Mehdi Dadashpour, Elahe Derakhshan, Vahid Vahedian, Seyed Abbas Shahrtash, Akram Firouzi Amandi, Majid Eslami, Maliheh Hasannia, Zahra Mehrabi and Leila Roshangar
    Citation: Cancer Nanotechnology 2024 15:58
  23. Liver and breast cancers are among the leading causes of cancer-related deaths worldwide, prompting researchers to seek natural anticancer agents and reduce chemotherapy side effects. Red beetroot (Beta vulgaris ...

    Authors: Mai G. Awad, Nemany A. N. Hanafy, Ramadan A. Ali, Dalia D. Abd El‑Monem, Sara H. El-Shafiey and Mohammed A. El‑Magd
    Citation: Cancer Nanotechnology 2024 15:57
  24. Breast cancer, a major health concern globally, often faces challenges in the non-invasive elimination of cancer cells. This has prompted researchers to explore alternative strategies, such as photothermal the...

    Authors: Yifan Li, Chao Huang, Zhengbin Wang, Rui Tan, Xianchun Fu, Kaikai Xu, Qingsong Niu, Di Zhong, Mingyun Hong, Yanfeng Shi and Pengfei Zhang
    Citation: Cancer Nanotechnology 2024 15:56
  25. We prepared novel plasmon-coupled silver (Ag) and silver oxide (Ag2O) nanoparticles using green synthesis and a magnetic stirrer device from lemon juice. Firstly, we prepared six Ag samples from green tea and lem...

    Authors: A. Kamal Mohamed, S. I. El-Dek, Saad M. EL-Gendy and Ahmed. A. G. El-Shahawy
    Citation: Cancer Nanotechnology 2024 15:55
  26. The manipulation of CD8+ T cell functions through genetic modifications presents a novel approach to cancer immunotherapy. This study aimed to explore the effects of IL2RG-overexpressing CD8+ T cells and assess t...

    Authors: Ying Li, Fang Huang, Ruoying Deng and Da Jiang
    Citation: Cancer Nanotechnology 2024 15:54
  27. Breast cancer has become the most prevalent malignancy among women, and it is estimated to comprise over 30% of all cancer cases diagnosed in women. This study evaluates the antitumor effects of a green-synthe...

    Authors: Ziba Ahmadi, Abolfazl Bayrami, Saber Zahri, Shima Rahim Pouran and Aziz Habibi-Yangjeh
    Citation: Cancer Nanotechnology 2024 15:53
  28. Cancer, a leading cause of mortality worldwide, continues to pose significant challenges in treatment and management. Conventional therapies often face limitations, including lack of selectivity, adverse effec...

    Authors: Mostafa M. El-Sheekh, El-Refaie Kenawy, Wesam E. Yousuf and Tarek M. Mohamed
    Citation: Cancer Nanotechnology 2024 15:52
  29. Doxorubicin (DOX) is the most common treatment for breast cancer, but its effectiveness is limited by drug resistance and dose variability. Evidence suggests that nanozymes can significantly improve drug penet...

    Authors: Majid Sharifi, Mohammad Kamalabadi-Farahani, Amir-Abas Salmani and Mahmoud Malaki
    Citation: Cancer Nanotechnology 2024 15:51
  30. Major therapeutic developments have been made in the prevention of head and neck cancer (HNC), and crucial measures have been implemented for the survival of patients. The advent of cancer nano-theranostic as ...

    Authors: Kaumudi Pande, B. K. Bettadaiah and Anbarasu Kannan
    Citation: Cancer Nanotechnology 2024 15:50
  31. Developing a drug delivery system that can transport a higher concentration to the target cells can improve therapeutic efficacy. This study aimed to develop a novel delivery system for acetyl-11-keto-beta-bos...

    Authors: Atiyeh Ale-Ahmad, Sohrab Kazemi, Abdolreza Daraei, Mahdi Sepidarkish, Ali Akbar Moghadamnia and Hadi Parsian
    Citation: Cancer Nanotechnology 2024 15:49
  32. Cancer cells can resist chemotherapy through various mechanisms, diminishing treatment outcomes. Research had indicated that combining miR-122 with doxorubicin (DOX) can improve hepatocellular carcinoma (HCC) ...

    Authors: Xiuyun Lin, Jie Liu, Guangfeng Wu, Xiu Yang, Wenqiang Yan, Nanfeng Fan and Hui Li
    Citation: Cancer Nanotechnology 2024 15:48

    The Correction to this article has been published in Cancer Nanotechnology 2024 15:61

  33. Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer. Radiation therapy (RT) is a modality for TNBC management. Radiosensitizers can mitigate the adverse effects of RT. Applying green...

    Authors: Soheila Montazersaheb, Aziz Eftekhari, Amir Shafaroodi, Soodeh Tavakoli, Sara Jafari, Ayşe Baran, Mehmet Fırat Baran, Sevda Jafari and Elham Ahmadian
    Citation: Cancer Nanotechnology 2024 15:47
  34. Sono-photodynamic therapy (SPDT), which combines photodynamic (PDT) and sonodynamic (SDT) therapies with sensitizers, offers new avenues for cancer treatment. Even though new sensitizers for SPDT have been syn...

    Authors: Samir Ali Abd El-Kaream, Doha Farhat Mohamed Zedan, Hagar Mohamed Mohamed, Amal Saleh Mohamed Soliman, Sohier Mahmoud El-Kholey and Mohammed Kamal El-Dein Nasra
    Citation: Cancer Nanotechnology 2024 15:46
  35. To investigate the ability of extracellular vesicles (EVs) to deliver oxaliplatin to epidermal growth factor receptor (EGFR+) colorectal cancer cells and increase oxaliplatin’s cytotoxicity.

    Authors: Shang-Tao Chien, Yi-Jung Huang, Ming-Yii Huang, Yi-Ping Fang, Shi-Wei Chao, Chia-Tse Li, Wun-Ya Jhang, Yun-Han Hsu, Shuo-Hung Wang and Chih-Hung Chuang
    Citation: Cancer Nanotechnology 2024 15:45
  36. Since wound healing requires cells to repopulate a damaged area, cell migration is essential. In addition, migration plays a crucial role in cancer metastasis. Whether tumour cells can invade tissue and metast...

    Authors: Claudia Reyes-San-Martin, Arturo Elías-Llumbet, Thamir Hamoh, Rokshana Sharmin, Yue Zhang, Angela Hermann, Willem Woudstra, Aldona Mzyk and Romana Schirhagl
    Citation: Cancer Nanotechnology 2024 15:44
  37. The purpose of this study was biogenic synthesis of silver nanoparticles using aqueous leaf extract of Cissus woodrowii (CW-AgNPs) and exploration of their role in inhibition cell proliferation of breast cancer c...

    Authors: Kailas D. Datkhile, Pratik P. Durgawale, Nilam J. Jagdale, Ashwini L. More and Satish R. Patil
    Citation: Cancer Nanotechnology 2024 15:43
  38. Colorectal Cancer (CRC) is the second leading cause of death among tumors worldwide. Conventional treatments are often accompanied by emerging immunotherapies, trying to reduce the burden of advanced and metas...

    Authors: Giada Rosso, Giulia Mesiano, Bianca Dumontel, Marco Carofiglio, Marzia Conte, Alessandro Grattoni and Valentina Cauda
    Citation: Cancer Nanotechnology 2024 15:42
  39. Authors: Huei-Jen Chen, Yi-An Cheng, Yu-Tung Chen, Chia-Ching Li, Bo-Cheng Huang, Shih-Ting Hong, I.-Ju Chen, Kai-Wen Ho, Chiao-Yun Chen, Fang-Ming Chen, Jaw-Yuan Wang, Steve R. Rofer, Tian-Lu Cheng and Tung-Ho Wu
    Citation: Cancer Nanotechnology 2024 15:41

    The original article was published in Cancer Nanotechnology 2023 14:78

  40. Magnetic fluid hyperthermia (MFH) represents a promising therapeutic strategy in cancer utilizing the heating capabilities of magnetic nanoparticles when exposed to an alternating magnetic field (AMF). Because...

    Authors: Malgorzata Sikorska, Grzegorz Domanski, Magdalena Bamburowicz-Klimkowska, Artur Kasprzak, Anna M. Nowicka, Monika Ruzycka-Ayoush and Ireneusz P. Grudzinski
    Citation: Cancer Nanotechnology 2024 15:38
  41. Designing and preparing a co-delivery system based on polymeric micelles have attracted in recent years. Co-delivery of anti-cancer agents within pH-sensitive polymeric micelles could provide superior advantag...

    Authors: Leila Farhoudi, Seyedeh Maryam Hosseinikhah, Amin Kazemi-Beydokhti, Leila Arabi, Seyedeh Hoda Alavizadeh, Seyedeh Alia Moosavian and Mahmoud Reza Jaafari
    Citation: Cancer Nanotechnology 2024 15:37
  42. Resveratrol (RVS) is a stilbene derivative polyphenolic compound extensively recognized for its anti-inflammatory, antioxidant and anti-aging properties, along with its enormous promise in carcinoma treatment....

    Authors: Mai O. Kadry
    Citation: Cancer Nanotechnology 2024 15:36
  43. Anlotinib is a targeted therapy indicated for some malignancies, including advanced non-small cell lung cancer (NSCLC). However, noninvasive biomarkers for identifying patients who will benefit from this disea...

    Authors: Aimi Huang, Fuchuang Zhang, Jiyang Zhang, Xiaoya Xu, Zhikuan Li, Sheng Chen, Baoning Nian, Dadong Zhang, Baohui Han, Aiqin Gu and Weimin Wang
    Citation: Cancer Nanotechnology 2024 15:35

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 4.5
    5-year Journal Impact Factor: 5.1
    Source Normalized Impact per Paper (SNIP): 0.723
    SCImago Journal Rank (SJR): 0.671

    Speed 2024
    Submission to first editorial decision (median days): 9
    Submission to acceptance (median days): 107

    Usage 2024
    Downloads: 274,722
    Altmetric mentions: 18